Literature DB >> 35382511

Local dynamics of pharmaceutical powder fluidization using high speed long distance microscopy and particle image velocimetry.

K Elserfy1, S Cheng1, H-K Chan2, A Kourmatzis3.   

Abstract

The local dynamics of fluidized pharmaceutical carrier powders in a turbulent channel flow was studied using particle image velocimetry (PIV) and High-speed, long-distance microscopy (HS-LDM). Four different lactose powders which have been used as a drug carrier in dry powder inhalers were used in this study. These powders have median powder particle diameters ranging between 61 and 121 μm. Air flow velocities ranging between 13.3 m/s and 66.7 m/s were examined. In addition, the effect of grid blockage ratio (ranging from ~25% to ~40% of the area of channel cross-section) was also investigated. Results show that the high-speed, long-distance microscopy (HS-LDM) technique was able to capture the mean velocity of the particles, and the results corresponded well with the PIV measurements. Results from the high-speed, long-distance microscopy (HS-LDM) method also demonstrate that the span of particle velocity closely follows that of the particle size distribution both for cohesive and non-cohesive powders. This study contributes towards an improved understanding of pharmaceutical carrier dynamics in turbulent channel flows and demonstrates how advanced image processing can be used to capture local particle dynamics.

Entities:  

Keywords:  Advanced imaging techniques; Dry powder inhalers; Lactose carriers; Pharmaceutical carriers; Two-phase flow

Year:  2021        PMID: 35382511      PMCID: PMC8978356          DOI: 10.1016/j.expthermflusci.2021.110367

Source DB:  PubMed          Journal:  Exp Therm Fluid Sci        ISSN: 0894-1777            Impact factor:   3.370


  16 in total

1.  Deagglomeration of dry powder pharmaceutical aerosols.

Authors:  Austin Voss; Warren H Finlay
Journal:  Int J Pharm       Date:  2002-11-06       Impact factor: 5.875

Review 2.  Dry powder inhalers for pulmonary drug delivery.

Authors:  H W Frijlink; A H De Boer
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

Review 3.  Dry powder aerosol delivery systems: current and future research directions.

Authors:  Hak-Kim Chan
Journal:  J Aerosol Med       Date:  2006

4.  The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations.

Authors:  Jagdeep Shur; Haggis Harris; Matthew D Jones; J Sebastian Kaerger; Robert Price
Journal:  Pharm Res       Date:  2008-02-01       Impact factor: 4.200

5.  Experimental investigation of design parameters on dry powder inhaler performance.

Authors:  Nguyen Thi Quynh Ngoc; Lusi Chang; Xinli Jia; Raymond Lau
Journal:  Int J Pharm       Date:  2013-09-18       Impact factor: 5.875

6.  Effect of an upstream grid on the fluidization of pharmaceutical carrier powders.

Authors:  K Elserfy; A Kourmatzis; H-K Chan; R Walenga; S Cheng
Journal:  Int J Pharm       Date:  2020-01-24       Impact factor: 5.875

Review 7.  A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?

Authors:  A H de Boer; H K Chan; R Price
Journal:  Adv Drug Deliv Rev       Date:  2011-04-23       Impact factor: 15.470

8.  Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.

Authors:  Estelle Guenette; Andrew Barrett; Debbie Kraus; Rachel Brody; Ljiljana Harding; Gavin Magee
Journal:  Int J Pharm       Date:  2009-07-09       Impact factor: 5.875

9.  Experimental observations of dry powder inhaler dose fluidisation.

Authors:  Rob Tuley; John Shrimpton; Matthew D Jones; Rob Price; Mark Palmer; Dave Prime
Journal:  Int J Pharm       Date:  2008-04-01       Impact factor: 5.875

Review 10.  Influence of physical properties of carrier on the performance of dry powder inhalers.

Authors:  Tingting Peng; Shiqi Lin; Boyi Niu; Xinyi Wang; Ying Huang; Xuejuan Zhang; Ge Li; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2016-05-04       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.